5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | NEUTRAL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.84▲ | 0.84▲ | 0.85▼ | 0.95▼ | 0.79▲ |
MA10 | 0.84▲ | 0.86▼ | 0.87▼ | 0.89▼ | 0.75▲ |
MA20 | 0.85▼ | 0.88▼ | 0.91▼ | 0.80▲ | 1.10▼ |
MA50 | 0.88▼ | 0.95▼ | 0.95▼ | 0.75▲ | 6.79▼ |
MA100 | 0.92▼ | 0.94▼ | 0.84▲ | 1.15▼ | N/A |
MA200 | 1.00▼ | 0.83▲ | 0.76▲ | 5.97▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.000▲ | -0.009▼ | 0.018▲ | 0.377▲ |
RSI | 32.369▼ | 32.319▼ | 35.777▼ | 51.819▲ | 29.671▼ |
STOCH | 84.722▲ | 6.432▼ | 12.204▼ | 48.900 | 30.118 |
WILL %R | 0.000▲ | -95.281▼ | -97.425▼ | -72.943 | -73.130 |
CCI | 460.407▲ | -75.264 | -94.057 | 0.680 | 52.109 |
Tuesday, May 13, 2025 12:10 AM
Neumora Therapeutics Inc (NMRA) showcases strategic advancements and financial resilience, despite challenges in clinical trials and increased net loss.
|
Monday, May 12, 2025 05:00 PM
The latest price target for Neumora Therapeutics (NASDAQ:NMRA) was reported by Needham on May 13, 2025. The analyst firm set a price target for $5.00 expecting NMRA to rise to within 12 months (a ...
|
Sunday, May 11, 2025 05:00 PM
Neumora Therapeutics, Inc. Common Stock (NASDAQ:NMRA) Q1 2025 Earnings Call Transcript May 12, 2025 Neumora Therapeutics, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.42 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 0.875 | 0.8865 | 0.8052 | 0.8445 | 592,105 |
12/06/25 | 0.93 | 0.9915 | 0.8977 | 0.8978 | 570,000 |
11/06/25 | 1.05 | 1.05 | 0.9069 | 0.9217 | 1,123,373 |
10/06/25 | 1.09 | 1.14 | 1.02 | 1.02 | 817,263 |
09/06/25 | 1.14 | 1.34 | 1.08 | 1.09 | 3,256,769 |
06/06/25 | 0.84 | 1.05 | 0.8125 | 1.02 | 1,844,741 |
05/06/25 | 0.83 | 0.85 | 0.791 | 0.8101 | 544,859 |
04/06/25 | 0.747 | 0.8051 | 0.7391 | 0.79 | 624,814 |
03/06/25 | 0.7481 | 0.7776 | 0.72 | 0.7431 | 607,556 |
02/06/25 | 0.69 | 0.7483 | 0.69 | 0.7479 | 634,184 |
|
|
||||
|
|
||||
|
|